Regular ArticlePelvic and Paraortic Lymph Nodal Status in Advanced Ovarian Cancer and Survival
References (12)
Survival of ovarian carcinoma with or without lymph node metastasis
Gynecol Oncol
(1987)- et al.
Pelvic and paraaortic lymphadenectomy in cancer of the ovary
Bailliere's Clin Obstet Gynecol
(1989) Systematic pelvic and paraaortic lymphadenectomy for advanced ovarian cancer—therapeutic advance or surgical folly
Gynecol Oncol
(1995)- et al.
Patterns of pelvic and paraaortic lymph node involvement in ovarian cancer
Gynecol Oncol
(1991) - et al.
Assessment of metastases to aortic and pelvic lymph nodes in epithelial ovarian carcinoma
Cancer
(1996)
Cited by (32)
Epithelial ovarian cancer
2023, DiSaia and Creasman Clinical Gynecologic OncologyEpithelial ovarian cancer
2018, Clinical Gynecologic OncologyPrognostic significance of systematic lymphadenectomy as part of primary debulking surgery in patients with advanced ovarian cancer
2012, Gynecologic OncologyCitation Excerpt :A recent retrospective review analyzing data from previous randomized trials demonstrated that a survival benefit may be associated with lymphadenectomy in advanced ovarian cancer patients [16]. However, other investigators have questioned the therapeutic efficacy of systematic lymphadenectomy [17,18]. The only randomized controlled trial (RCT) comparing systemic pelvic and para-aortic lymphadenectomy with resection of bulky nodes only demonstrated that systemic lymphadenectomy did not improve overall survival in advanced ovarian cancer [19].
Computer tomography, magnetic resonance imaging, and positron emission tomography or positron emission tomography/computer tomography for detection of metastatic lymph nodes in patients with ovarian cancer: A meta-analysis
2012, European Journal of RadiologyCitation Excerpt :Ovarian cancer is the fifth most common cause of cancer death and accounts for over half of all deaths related to gynecologic cancer [1]. Nodal metastases are common, particularly in advanced (stages III–IV) ovarian tumors, with an incidence of 35–78% [2,3]. Metastasis to lymph nodes has an important impact on the overall stage of ovarian cancer, on how these patients are treated and on the prognosis.
Epithelial Ovarian Cancer
2012, Clinical Gynecologic Oncology: Eighth EditionThe place of lumo-aortic and pelvic lymph node dissection in the treatment of ovarian cancer
2008, Journal de Chirurgie